Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials
aDiane M. Thiboutot, MD; bLeon Kircik, MD; cAmy McMichael, MD; dFran E. Cook-Bolden, MD; eStephen K. Tyring, MD, PhD; fDavid R. Berk, MD; fJoan-En Chang-Lin, PhD; fVince Lin, PhD; fAlexandre